JP2023536938A5 - - Google Patents

Info

Publication number
JP2023536938A5
JP2023536938A5 JP2023507688A JP2023507688A JP2023536938A5 JP 2023536938 A5 JP2023536938 A5 JP 2023536938A5 JP 2023507688 A JP2023507688 A JP 2023507688A JP 2023507688 A JP2023507688 A JP 2023507688A JP 2023536938 A5 JP2023536938 A5 JP 2023536938A5
Authority
JP
Japan
Prior art keywords
compound
crystalline form
quinazolin
benzonitrile
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023507688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023536938A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/057165 external-priority patent/WO2022029656A1/en
Publication of JP2023536938A publication Critical patent/JP2023536938A/ja
Publication of JP2023536938A5 publication Critical patent/JP2023536938A5/ja
Priority to JP2025147197A priority Critical patent/JP2026004313A/ja
Pending legal-status Critical Current

Links

JP2023507688A 2020-08-06 2021-08-04 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤 Pending JP2023536938A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025147197A JP2026004313A (ja) 2020-08-06 2025-09-04 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2020107444 2020-08-06
CNPCT/CN2020/107444 2020-08-06
PCT/IB2021/057165 WO2022029656A1 (en) 2020-08-06 2021-08-04 Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025147197A Division JP2026004313A (ja) 2020-08-06 2025-09-04 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤

Publications (2)

Publication Number Publication Date
JP2023536938A JP2023536938A (ja) 2023-08-30
JP2023536938A5 true JP2023536938A5 (https=) 2024-08-13

Family

ID=77358315

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023507688A Pending JP2023536938A (ja) 2020-08-06 2021-08-04 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤
JP2025147197A Pending JP2026004313A (ja) 2020-08-06 2025-09-04 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025147197A Pending JP2026004313A (ja) 2020-08-06 2025-09-04 ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの結晶形態及びその製剤

Country Status (5)

Country Link
US (1) US12459902B2 (https=)
EP (1) EP4192466A1 (https=)
JP (2) JP2023536938A (https=)
CN (1) CN116419918A (https=)
WO (1) WO2022029656A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4431497A1 (en) * 2019-02-15 2024-09-18 Bausch + Lomb Ireland Limited Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
GB0525068D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
US20150352176A1 (en) * 2014-06-06 2015-12-10 Newport Research, Inc. Oil-free and fat-free aqueous suspensions of cyclosporin
JP6994061B2 (ja) * 2019-02-15 2022-01-14 ノバルティス アーゲー ４－（７－ヒドロキシ－２－イソプロピル－４－オキソ－４ｈ－キナゾリン－３－イル）－ベンゾニトリルの製剤
KR20210129677A (ko) * 2019-02-15 2021-10-28 노파르티스 아게 안구 표면 통증의 치료 방법
EP4431497A1 (en) * 2019-02-15 2024-09-18 Bausch + Lomb Ireland Limited Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof

Similar Documents

Publication Publication Date Title
JP2022017260A5 (https=)
JP2022516099A5 (https=)
JP4153563B2 (ja) 医薬組成物
TW201143783A (en) Non-irritating ophthalmic povidone-iodine compositions
JP6683622B2 (ja) 眼科用水性組成物
KR100546450B1 (ko) 약학 조성물
JP2015521617A5 (https=)
JP2022505637A5 (https=)
JP2023536509A5 (https=)
JP2023512763A5 (https=)
JP2024544538A5 (https=)
JPWO1999036065A1 (ja) 医薬組成物
FI120403B (fi) 4-(2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena
JP2023536938A5 (https=)
JP6404358B2 (ja) マルトール第二鉄の結晶形態
JP2022520410A5 (https=)
JP2002505328A (ja) 抗潰瘍医薬の硝酸塩
TWI838482B (zh) 心肌肌鈣蛋白活化劑之多晶型物及共晶
KR20220110726A (ko) 트리아졸 항진균 화합물 pc945의 다형체
WO2006132342A1 (ja) ロフルミラスト点眼液
ES2218146T3 (es) Derivado de tiazolidinadiona y su uso como antidiabetico.
JP2001114700A (ja) 点眼剤組成物
JP2025142200A (ja) ダプトマイシン製剤
US20150328215A1 (en) Stable amorphous raltegravir potassium premix and process for the preparation thereof
JPH10338638A (ja) 損傷皮膚修復用製剤